2022-08-26 | Harvard Bioscience, Inc. HBIO | 9,291 0.0231% | $3.41 | $31,682 | -5.78% | |||
2022-08-24 | Harvard Bioscience, Inc. HBIO | 8,244 0.0207% | $3.34 | $27,535 | -2.82% | |||
2022-08-22 | Harvard Bioscience, Inc. HBIO | 4,918 0.0118% | $3.16 | $15,541 | -2.21% | |||
2022-08-18 | Harvard Bioscience, Inc. HBIO | 1,151 0.0028% | $3.19 | $3,672 | -2.52% | |||
2021-08-11 | Sale | Entegris, Inc. ENTG | President & CEO | 23,710 0.0176% | $116.66 | $2.77M | +4.71% | |
2021-08-10 | Sale | Entegris, Inc. ENTG | President & CEO | 65,000 0.048% | $120.03 | $7.8M | +1.45% | |
2021-08-09 | Sale | Entegris, Inc. ENTG | President & CEO | 74,806 0.0551% | $121.49 | $9.09M | 0% | |
2021-08-04 | Sale | Entegris, Inc. ENTG | President & CEO | 56,178 0.0418% | $125.44 | $7.05M | -1.96% | |
2021-04-14 | Sale | Entegris, Inc. ENTG | President & CEO | 100,000 0.0741% | $118.43 | $11.84M | +4.08% | |
2021-04-13 | Sale | Entegris, Inc. ENTG | President & CEO | 100,000 0.0736% | $117.96 | $11.8M | +3.81% | |
2021-04-12 | Sale | Entegris, Inc. ENTG | President & CEO | 100,000 0.0736% | $119.36 | $11.94M | +2.6% | |
2021-04-05 | Sale | Entegris, Inc. ENTG | President & CEO | 300,444 0.2222% | $120.69 | $36.26M | +2% | |
2020-07-31 | Sale | Entegris, Inc. ENTG | President & CEO | 118,520 0.0877% | $71.80 | $8.51M | +41.22% | |
2020-07-27 | Sale | Entegris, Inc. ENTG | President & CEO | 75,943 0.0564% | $69.64 | $5.29M | +43.39% | |
2019-11-13 | Harvard Bioscience, Inc. HBIO | director | 6,100 0.0166% | $2.52 | $15,372 | +22.45% | ||
2019-11-12 | Harvard Bioscience, Inc. HBIO | director | 10,579 0.028% | $2.51 | $26,553 | +19.52% | ||
2019-11-11 | Harvard Bioscience, Inc. HBIO | director | 12,855 0.0341% | $2.59 | $33,294 | +16.28% | ||
2019-11-08 | Harvard Bioscience, Inc. HBIO | director | 6,616 0.0169% | $2.64 | $17,466 | +9.12% | ||
2019-09-13 | Harvard Bioscience, Inc. HBIO | director | 7,372 0.0191% | $3.11 | $22,927 | -7.28% | ||
2019-09-12 | Harvard Bioscience, Inc. HBIO | director | 11,297 0.0293% | $3.07 | $34,682 | -5.63% |